Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Tdf-Study'
Tdf-Study published presentations and documents on DocSlides.
Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials
by luanne-stotts
Progressive rises in weight and clinical obesity ...
Switch from Efavirenz + ZDV-3TC to Efavirenz + TDF-FTC
by ramon803
SWEET Trial . Switch to Efavirenz + TDF-FTC . SWEE...
Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV
by kylo
Andrew Hill, Francois Venter, Eric . Delaporte. , ...
TDF-FTC versus Placebo as HIV PrEP for Transgender Women
by shmuel184
iPrEx. Trial . Substudy. TDF-FTC versus Placebo a...
Switch to DOR-TDF-3TC vs. Continued Baseline Regimen
by dorothy
DRIVE SHIFT. Switch to Doravirine-TDF-3TC versus C...
Switching to TDF-FTC from ABC-3TC for Hyperlipidemia
by trinity
ROCKET II. Switching to TDF-FTC from ABC-3TC . for...
DTG + 3TC versus DTG + TDF-FTC as Initial ART
by della
GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...
Switching to TAF from TDF, each with RPV and FTC
by julia
Study GS-366-1216. Switch from TDF to TAF, each wi...
Switch de TDF a TAF Estudio GS-US-292-0109
by calandra-battersby
Estudio GS-US-311-1089 . Estudio GS-US-366-1216 ....
EFFECTS ON RENAL FUNCTION OF A SWITCH FROM TENOFOVIR (TDF)
by tawny-fly
M Harris, . S Guillemi. , K Chan, B Yip. ,. . M ...
Raltegravir plus Ritonavir-Boosted Darunavir NEAT001/ANRS 143 Trial
by matthew167
NEAT001/ANRS 143 Trial. Darunavir/r + Raltegravir ...
Cases from the Clinic(ians): Case-based Panel Discussion
by tripp
Associate Dean for Global Health. University of Al...
Switch from EFV plus ABC-3TC to EFV-TDF-FTC ROCKET-1 Trial
by ricardo
ROCKET-1 Trial. Switch from EFV + ABC-3TC to EFV-T...
Switching from TDF/FTC to TAF/
by fanny
FTC. Study 311-1089. Switching from TDF/FTC to TAF...
EFV versus ATV + RTV, both with ABC-3TC or TDF-FTC
by felicity
ACTG 5202. EFV versus ATV/r, both with ABC-3TC or ...
Optimization of Antiretroviral Therapy
by belinda
With Emergence of Comorbidities. Roger J. . Bedimo...
Retirement Plan Consulting
by oconnor
Overview of Services. Table of Contents. About RPA...
HIV 2020: Time for change
by garcia
Dr. Kay Mahomed. Netcare. Garden City Clinic. Ma...
Cabotegravir, Long-acting Injectable
by jacey
Last Updated: October 6, 2023. Prepared by:. David...
Jeanne Marrazzo, MD, MPH
by rose
Professor of Medicine. University of Washington. S...
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
by jasmine
–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...
Total Soluble and Insoluble Dietary Fibre Contents of Wild Growing E
by alyssa
302 Vol. 32, 2014, No. 3: 302307Czech J. Fo...
Eric S. Daar , MD Michael S.
by ButterflyHeart
Saag. , MD. Antiretroviral Therapy:. A Case-Based ...
Renal and Bone Safety of
by ashley
Tenofovir. . Alafenamide. . vs. . Tenofovir. ....
Target Date Funds and P
by unita
lan . S. ponsor Responsibilities. Marcia S. Wagner...
Selecting an Initial Antiretroviral Therapy (ART) Regimen
by cappi
www.hivguidelines.org. Purpose of . This Guideline...
937401234123534671341849346744x 19 333133Webinar Requirements A c
by erica
HBcAbThis prescribe ARTART Dispensed0-5-14 Days0-1...
WHO ARV Forecasting Meeting
by sistertive
Geneva, March 19 - 20 , 2015 1 | Treatment and C...
Comparison of RTV vs Cobi
by studmonkeybikers
GS-US-216-0114. . Gallant JE. JID 2013;208:32-9...
Evolving Options for HBV Therapy:
by desiron
Navigating the New Treatment Landscape. Outline. I...
Joel E. Gallant, MD, MPH
by mastervisa
Medical Director, Specialty . Services. Southwest ...
HIV Update Ardis Moe, M.D.
by nonhurmer
amoe@mednet.ucla.edu. UCLA CARE clinic/NEVHC Van N...
Use of HCV DAAs with HIV Regimens
by robaut
Sam Lam, . PharmD. Annie Vong, . PharmD. 2/3/2017....
HIV Medicine From Guidelines to Practice
by jubilantbikers
Kiat. . Ruxrungtham. Professor of Medicine, . Chu...
Common Pharmacomistakes in Advanced Illness
by tawny-fly
Common Pharmacomistakes in Advanced Illness Opioi...
Gilead Sciences, Inc., Foster City, CA, USA
by phoebe-click
Gilead Sciences, Inc., Foster City, CA, USA FTC/T...
“On Demand” Oral PrEP: Lessons Learned from Macaque Models
by giovanna-bartolotta
“On Demand” Oral PrEP: Lessons Learned from M...
Pre-Exposure Prophylaxis ( PrEP ) for HIV Infection Jeffrey D. Klausner, MD, MPH
by kittie-lecroy
Pre-Exposure Prophylaxis ( PrEP ) for HIV Infect...
ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals
by phoebe-click
ACTIVITY CODE . TD342. Antiretroviral Medications...
How to assess the efficacy of new strategies for the prevention of HIV – experience from the HVTN
by tawny-fly
Sinead Delany-Moretlwe. Wits RHI, University of t...
Load More...